Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften Toetsvragen Web-tv Video Audio
Tips voor Mijn BSL
Inloggen
Top
Quality of Life Research
Gepubliceerd in:

01-06-2014

Relationship of EQ-5D quality of life with the presence of co-morbidity and extra-articular features in patients with rheumatoid arthritis

Auteurs: Michael A. Crilly, Marjorie C. Johnston, Corri Black

Gepubliceerd in: Quality of Life Research | Uitgave 5/2014

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

Rheumatoid arthritis (RA) is associated with extra-articular features (ExRA) and other co-morbidities. The aim of this study is to quantify their relative contribution to quality of life (QOL) in patients with RA.

Methods

A consecutive series of 114 ambulatory RA patients aged between 40 and 65 years were assessed by a research nurse on a single occasion. Assessment included a patient questionnaire (including EQ-5D), medication review and fasting venous blood sample. Medical records were reviewed by a rheumatologist for co-existing conditions. Multiple linear regression was used to adjust mean differences in EQ-5D in the presence/absence of co-existing conditions for age, sex, university education, arthritis duration, rheumatoid factor, erythrocyte sedimentation rate, current disease-modifying drug therapy, previous hand joint erosions and joint surgery.

Results

Mean age was 54 years (82 % female) and median arthritis duration 10 years. Unadjusted EQ-5D was −0.09 (95 % CI −0.18 to −0.01) lower in patients with any co-existing condition. EQ-5D scores were inversely correlated with the overall number of co-existing conditions (Spearman’s ρ −0.31, p = 0.001), number of co-morbidities (ρ −0.22, p = 0.02) and number of ExRA features (ρ −0.22, p = 0.02). There was a linear trend of lower EQ-5D with increasing number of co-existing conditions (p = 0.003). EQ-5D was −0.18 (95 % CI −0.33 to −0.02) lower in the presence of more than two co-existing conditions compared to none. Co-morbidity and ExRA features were associated with comparable adjusted reductions (−0.05 vs. −0.06) in EQ-5D scores.

Conclusion

A wide range of co-existing conditions are associated with poorer QOL in patients with RA.
vorige artikel Quality of life assessed with EQ-5D in patients undergoing glioma surgery: What is the responsiveness and minimal clinically important difference?
volgende artikel Using existing data to identify candidate items for a health state classification system in multiple sclerosis
Bijlagen
Alleen toegankelijk voor geautoriseerde gebruikers
Literatuur
1.
2.
Huntley, A. L., Johnson, R., Purdy, S., Valderas, J. M., & Salisbury, C. (2012). Measures of multimorbidity and morbidity burden for use in primary care and community settings: A systematic review and guide. The Annals of Family Medicine, 10, 134–141.CrossRef
3.
Barnett, K., Mercer, S. W., Norbury, M., Watt, G., Wyke, S., & Guthrie, B. (2012). Epidemiology of multimorbidity and implications for health care, research, and medical education, a cross-sectional study. Lancet, 380, 37–43.PubMedCrossRef
4.
Diederichs, C., Berger, K., & Bartels, D. B. (2011). The measurement of multiple chronic diseases—a systematic review on existing multimorbidity indices. The Journals of Gerontology Series A: Biological Sciences and Medical Sciences, 66, 301–311.CrossRef
5.
Prete, M., Racanelli, V., Digiglio, L., Vacca, A., Dammacco, F., & Perosa, F. (2011). Extra-articular manifestations of rheumatoid arthritis: An update. Autoimmunity Reviews, 11, 123–131.PubMedCrossRef
6.
Turesson, C., Jacobsson, L., & Bergstrom, U. (1999). Extra-articular rheumatoid arthritis, prevalence and mortality. Rheumatology, 38, 668–674.PubMedCrossRef
7.
Turesson, C., O’Fallon, W. M., Crowson, C. S., Gabriel, S. E., & Matteson, E. L. (2002). Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. The Journal of Rheumatology, 29, 62–67.PubMed
8.
Turesson, C., McClelland, R. L., Christianson, T. J., & Matteson, E. L. (2006). Multiple extra-articular manifestations are associated with poor survival in patients with rheumatoid arthritis. Annals of the Rheumatic Diseases, 65, 1533–1534.PubMedCentralPubMedCrossRef
9.
Avina-Zubieta, J. A., Choi, H. K., Sadatsafavi, M., Etminan, M., Esdaile, J. M., & Lacaille, D. (2008). Risk of cardiovascular mortality in patients with rheumatoid arthritis: A meta-analysis of observational studies. Arthritis Care & Research, 59, 1690–1697.CrossRef
10.
Sharabiani, M. T., Aylin, P., & Bottle, A. (2012). Systematic review of comorbidity indices for administrative data. Medical Care, 50, 1109–1118.PubMedCrossRef
11.
Haroon, N., Aggarwal, A., Lawrence, A., Agarwal, V., & Misra, R. (2007). Impact of rheumatoid arthritis on quality of life. Modern Rheumatology, 17, 290–295.PubMedCrossRef
12.
Bedi, G. S., Gupta, N., Handa, R., Pal, H., & Pandey, R. M. (2005). Quality of life in Indian patients with rheumatoid arthritis. Quality of Life Research, 14, 1953–1958.PubMedCrossRef
13.
Eser, F., Garip, Y., & Bodur, H. (2012). Extraarticular manifestations in Turkish patients with rheumatoid arthritis, impact of EAMs on the health-related quality of life in terms of disease activity, functional status, severity of pain, and social and emotional functioning. Rheumatology International, 32, 1521–1525.PubMedCrossRef
14.
Lee, T. J., Park, B. H., Son, H. K., et al. (2012). Cost of illness and quality of life of patients with rheumatoid arthritis in South Korea. Value in Health, 15, S43–S49.PubMedCrossRef
15.
Wolfe, F., Michaud, K., Li, T., & Katz, R. S. (2010). Chronic conditions and health problems in rheumatic diseases, comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, systemic lupus erythematosus, and fibromyalgia. The Journal of Rheumatology, 37, 305–315.PubMedCrossRef
16.
Salaffi, F., Carotti, M., Ciapetti, A., Gasparini, S., & Grassi, W. (2011). A comparison of utility measurement using EQ-5D and SF-6D preference-based generic instruments in patients with rheumatoid arthritis. Clinical and Experimental Rheumatology, 29, 661–671.PubMed
17.
Radner, H., Smolen, J. S., & Aletaha, D. (2011). Comorbidity affects all domains of physical function and quality of life in patients with rheumatoid arthritis. Rheumatology, 50, 381–388.PubMedCrossRef
18.
Rupp, I., Boshuizen, H. C., Jacobi, C. E., Dinant, H. J., & van den Bos, G. (2004). Comorbidity in patients with rheumatoid arthritis: Effect on health-related quality of life. The Journal of Rheumatology, 31, 58–65.PubMed
19.
Crilly, M. A., Kumar, V., Clark, H. J., Scott, N. W., Macdonald, A. G., & Williams, D. J. (2009). Arterial stiffness and cumulative inflammatory burden in rheumatoid arthritis: A dose-response relationship independent of established cardiovascular risk factors. Rheumatology, 48, 1606–1612.PubMedCrossRef
20.
The EuroQol Group. (1990). EuroQol: A new facility for the measurement of health-related quality of life. Health Policy, 16, 199–208.CrossRef
21.
Kind, P., Dolan, P., Gudex, C., & Williams, A. (1998). Variations in population health status: Results from a United Kingdom national questionnaire survey. BMJ, 316, 736–741.PubMedCentralPubMedCrossRef
22.
Dolan, P., Gudex, C., Kind, P., & Williams, A. (1995). A social tariff for EuroQol, results from a UK general population survey. Centre For Health Economics. York: University of York. (Discussion Paper 138).
23.
Hurst, N. P., Kind, P., Ruta, D., Hunter, M., & Stubbings, A. (1997). Measuring health-related quality of life in rheumatoid arthritis: Validity, responsiveness and reliability of EuroQol (EQ-5D). Rheumatology, 36, 551–559.CrossRef
24.
Marra, C. A., Woolcott, J. C., Kopec, J. A., et al. (2005). A comparison of generic, indirect utility measures (the HUI2, HUI3, SF-6D, and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Social Science and Medicine, 60, 1571–1582.PubMedCrossRef
25.
Harrison, M. J., Davies, L. M., Bansback, N. J., Ingram, M., Anis, A. H., & Symmons, D. P. (2008). The validity and responsiveness of generic utility measures in rheumatoid arthritis: A review. The Journal of Rheumatology, 35, 592–602.PubMed
26.
Linde, L., Sorensen, J., Ostergaard, M., Horslev-Petersen, K., & Hetland, M. L. (2008). Health-related quality of life, validity, reliability, and responsiveness of SF-36, 15D, EQ-5D, RAQoL, and HAQ in patients with rheumatoid arthritis. The Journal of Rheumatology, 35, 1528–1537.PubMed
27.
Meijer, J. M., Meiners, P. M., Huddleston-Slater, J. J., et al. (2009). Health-related quality of life, employment and disability in patients with Sjogren’s syndrome. Rheumatology, 48, 1077–1082.PubMedCrossRef
28.
Atroshi, I., Gummesson, C., McCabe, S. J., & Ornstein, E. (2007). The SF-6D health utility index in carpal tunnel syndrome. Journal of Hand Surgery European, 32, 198–202.CrossRef
29.
Panoulas, V. F., Douglas, K. M., Milionis, H. J., et al. (2007). Prevalence and associations of hypertension and its control in patients with rheumatoid arthritis. Rheumatology, 46, 1477–1482.PubMedCrossRef
30.
Carmona, L., Gonzalez-Alvaro, I., Balsa, A., Angel, B. M., Tena, X., & Sanmarti, R. (2003). Rheumatoid arthritis in Spain: Occurrence of extra-articular manifestations and estimates of disease severity. Annals of the Rheumatic Diseases, 62, 897–900.PubMedCentralPubMedCrossRef
31.
Turesson, C., McClelland, R. L., Christianson, T., & Matteson, E. (2008). Clustering of extraarticular manifestations in patients with rheumatoid arthritis. The Journal of Rheumatology, 35, 179–180.PubMed
32.
Young, A., & Koduri, G. (2007). Extra-articular manifestations and complications of rheumatoid arthritis. Best Practice & Research Clinical Rheumatology, 21, 907–927.CrossRef
33.
Panoulas, V. F., Metsios, G. S., Pace, A. V., et al. (2008). Hypertension in rheumatoid arthritis. Rheumatology, 47, 1286–1298.PubMedCrossRef
34.
Palm, O., Garen, T., Enger, T. B., et al. (2008). Clinical pulmonary involvement in primary Sjogren’s syndrome: Prevalence, quality of life and mortality—a retrospective study based on registry data. Rheumatology, 52, 173–179.CrossRef
35.
Norton, S., Koduri, G., Nikiphorou, E., et al. (2013). A study of baseline prevalence and cumulative incidence of comorbidity and extra-articular manifestations in RA and their impact on outcome. Rheumatology, 52, 99–110.PubMedCrossRef
Metagegevens
Titel
Relationship of EQ-5D quality of life with the presence of co-morbidity and extra-articular features in patients with rheumatoid arthritis
Auteurs
Michael A. Crilly
Marjorie C. Johnston
Corri Black
Publicatiedatum
01-06-2014
Uitgeverij
Springer International Publishing
Gepubliceerd in
Quality of Life Research / Uitgave 5/2014
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-013-0597-0

Andere artikelen Uitgave 5/2014

Shifting responses in quality of life: People living with dialysis

Fatigue in patients with spinal muscular atrophy type II and congenital myopathies: evaluation of the fatigue severity scale

Testing gender invariance of the Hospital Anxiety and Depression Scale using the classical approach and Bayesian approach

Quality of life assessed with EQ-5D in patients undergoing glioma surgery: What is the responsiveness and minimal clinically important difference?

Quality of life in partners of patients with localised prostate cancer

The dyadic interaction of relationships and disability type on informal carer subjective well-being